The American Cancer Society says more people will be diagnosed with cancer this year than ever before. Conventional treatments like surgery, chemotherapy, and radiation are helping to prevent deaths, but can more be done? Emerging research focused on repurposed drugs is proving the answer is YES.

The FLCCC Alliance is proud to announce it has partnered with renowned breast cancer physician and researcher Kathleen Ruddy, MD, to conduct an observational study in collaboration with three U.S. clinics to track patient responses to various adjunct cancer therapies using repurposed drugs. The aim is to determine changes in the five-year survival rate of several types of cancer including breast, prostate, lung, and colorectal.

FLCCC observational cancer study announcement

Study Details